After Metformin: The Newest Oral Antidiabetic Therapies and Cardiovascular Safety – MOC Section 1
CAN-eng
$0
free
Cardiovascular, Diabetes, Endocrinology
1 Credits
Course Description
Course Details
Expiry Date: 2017-11-10
Faculty
Accreditation
Learning Objective(s)
- Describe the newest classes of oral antidiabetic therapy available in Canada and their role in the management of type 2 diabetes.
- Review the evidence for cardiovascular safety of the newest oral antidiabetic therapies.
- Examine the safety considerations when selecting an oral agent for the management of type 2 diabetes in patients with cardiovascular disease.